Showing results (2121-2130 of 2,211) with videos related to

Sort By:
Pageof 222
Biology Letters|January 21, 2025
A consensus on the definition of positive animal welfareJean-Loup Rault, Melissa Bateson, Alain Boissy, et al.
The Journal of Small Animal Practice|September 6, 2024
Placement, management and complications associated with peripheral intravenous catheter use in UK small animal practiceE Haskey, V Maund, F Allerton, et al.
Plos One|February 25, 2022
Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trialWestyn Branch-Elliman, Ryan Ferguson, Gheorghe Doros, et al.
Pharmacoepidemiology and Drug Safety|April 26, 2021
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims dataDaniel C Beachler, Devon H Taylor, Mary S Anthony, et al.
Schizophrenia (Heidelberg, Germany)|January 9, 2023
Gray matter volume drives the brain age gap in schizophrenia: a SHAP studyPedro L Ballester, Jee Su Suh, Natalie C W Ho, et al.
Health Technology Assessment (Winchester, England)|March 9, 2012
A pragmatic randomised controlled trial to evaluate the cost-effectiveness of a physical activity intervention as a treatment for depression: the treating depression with physical activity (TREAD) trialM Chalder, N J Wiles, J Campbell, et al.
Journal of the American College of Cardiology|July 15, 2017
Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical TrialJoseph G Rogers, Chetan B Patel, Robert J Mentz, et al.
The New England Journal of Medicine|February 12, 2015
Lenvatinib versus placebo in radioiodine-refractory thyroid cancerMartin Schlumberger, Makoto Tahara, Lori J Wirth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2026
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 StudyAdnan Khattak, Matteo S Carlino, Tarek Meniawy, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 30, 2025
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d'épisodes dépressifs pendant le traitement d'entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d'intégration des biomarqueurs pour la dépression (CAN-BIND)Raymond W Lam, Katerina Rnic, John-Jose Nunez, et al.
Pageof 222